Research News

Blood test may confirm parkinsons diagnosis

Making Strides Toward Parkinson’s Biomarker

Monday, 24 April 2017

At the current time, there is no identified biomarker for Parkinson’s disease (PD). In other words, there is no objective measure — no lab or imaging test, for example — that can tell whether a person has PD, what type…

Todd Sherer

MJFF CEO on Parkinson’s Disease 200th: “Hope Remains”

Monday, 17 April 2017

In recognition of Parkinson’s Awareness month, MJFF CEO Todd Sherer, PhD, penned an op-ed for Scientific American about the current state of Parkinson’s disease (PD) research, 200 years after Dr. James Parkinson formally characterised the disease. In the commentary, Dr….

New Research Confirms Role of LRRK2 in Immune Cells

Monday, 10 April 2017

Though associated with only a small percentage of total Parkinson’s cases, mutations of the LRRK2 gene are the greatest known genetic contributor to Parkinson’s disease (PD). Researchers are striving to understand the mechanisms of disease related to this mutation because…

Parkinson's Research

New Dyskinesia Drug Moving Forward in Clinical Testing

Sunday, 26 February 2017

A promising new therapeutic for Parkinson’s disease has secured funding for Phase II testing. The Michael J. Fox Foundation (MJFF) supported early research of this drug, paving the way for its advancement into clinical trials. Parkinson’s disease (PD) is typically…

Blood test may confirm parkinsons diagnosis

Blood Test May Help Confirm Parkinson’s Diagnosis

Monday, 20 February 2017

Parkinson’s disease (PD) is a complex and varied disorder with many different potential motor and non-motor symptoms. Early on, it can sometimes be difficult to determine whether symptoms are caused by Parkinson’s or an atypical parkinsonism, a condition that shares…

Blood test may confirm parkinsons diagnosis

Alpha-synuclein Antibody moves a step closer

Monday, 14 November 2016

Therapeutic projects against top target protein alpha-synuclein continue to march through clinical testing and closer to patient hands. Yesterday biotechnology company Prothena announced results from its Phase Ib trial of PRX002, an antibody under investigation as a treatment to slow…

Cognitive Impairment

Cognitive Changes in Parkinson’s Disease

Monday, 17 October 2016

Cognitive impairment, disturbance of memory, thinking and/or language abilities, is a non-motor symptom that can be associated with Parkinson’s. Cognitive disturbances can arise at any time in the course of Parkinson’s disease (PD) and vary widely in severity. Some people…

Neurons

Common Link across Different Causes of Parkinson’s?

Friday, 7 October 2016

Parkinson’s is a variable disease — different in age of onset, experience of symptoms and cause — but a new study points to a potential common link. “Finding a common mechanism behind different suspected causes of Parkinson’s suggests that there…

Vaccine for Parkinson’s Reports Positive Results from Boost Study

Monday, 12 September 2016

New study results from Austrian biotech AFFiRiS support continued development of its vaccine against the key Parkinson’s protein alpha-synuclein. Today the company announced its “boost” follow-up study — funded with a $1.04 million grant from The Michael J. Fox Foundation…